BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30644815)

  • 1. Personalized Treatment for Small Renal Tumors: Decision Analysis of Competing Causes of Mortality.
    Kang SK; Huang WC; Elkin EB; Pandharipande PV; Braithwaite RS
    Radiology; 2019 Mar; 290(3):732-743. PubMed ID: 30644815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Anatomy Scoring and Renal Function for Nephron-Sparing Treatment Selection in Patients With Small Renal Masses: A Microsimulation-Based Decision Analysis.
    Kang SK; Huang WC; Skolnik EY; Gervais DA; Braithwaite RS; Pandharipande PV
    AJR Am J Roentgenol; 2016 Aug; 207(2):344-53. PubMed ID: 27305103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
    J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
    Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
    Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
    Shi L; He Y; Liu C; Qian X; Wang Z
    Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate.
    Chung JS; Son NH; Lee SE; Hong SK; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
    J Korean Med Sci; 2018 Oct; 33(43):e277. PubMed ID: 30344463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma.
    Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K; Dhanji S; Cerrato C; Narasimhan R; Perry J; Master V; Fujii Y; Derweesh IH
    BJU Int; 2023 Feb; 131(2):219-226. PubMed ID: 35876044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of warm ischaemia time on postoperative renal function after partial nephrectomy for clinical T1 renal cell carcinoma: a propensity score-matched study.
    Lee H; Song BD; Byun SS; Lee SE; Hong SK
    BJU Int; 2018 Jan; 121(1):46-52. PubMed ID: 28749082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
    Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.